BELLEROPHON THERAPEUTICS INC (BLPH) Stock Analyst Earnings Estimates
NASDAQ:BLPH - Nasdaq - US0787713009 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A -100.00% | N/A | N/A -30.68% | N/A 96.52% | N/A 56.17% | N/A 27.30% | N/A 16.40% | ||||||||||
| EBITDA YoY % growth | -59.36M | -47.86M 19.37% | -23.36M 51.19% | -24.23M -3.72% | -27.52M -13.58% | -17.12M 37.79% | -26.13M -52.63% | -20.059M 23.23% | -22.319M -11.27% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -59.75M | -48.24M 19.26% | -23.76M 50.75% | -24.6M -3.54% | -27.88M -13.33% | -17.47M 37.34% | -26.28M -50.43% | -20.161M 23.28% | -22.384M -11.03% | N/A 45.42% | N/A -65.46% | N/A 329.80% | N/A -79.29% | N/A 237.63% | N/A 59.64% | N/A 29.63% | N/A 10.78% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -57.75 48.29% | -23.85 58.70% | N/A | -4.50 | -2.95 34.44% | -3.29 -11.53% | -1.88 42.86% | -2.08 -10.64% | N/A 50.96% | N/A -82.00% | N/A 180.77% | N/A -66.67% | N/A 232.65% | N/A 58.28% | N/A 28.29% | N/A 9.67% |
All data in USD
| Q3 / 23 | Q4 / 23 | |
|---|---|---|
| EPS Q2Q % growth | -0.45 15.32% | -0.43 19.17% |
| Revenue Q2Q % growth | ||
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -4.692M 8.29% | -4.547M 10.58% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | -0.42 2.33% | -0.43 | 0.01 | 1.96% |
| Q1 2023 Q2Q % growth | 0.27 145.76% | -0.50 | 0.77 | 153.48% |
| Q4 2022 Q2Q % growth | -0.53 -17.78% | -0.49 | -0.04 | -8.25% |
| Q3 2022 Q2Q % growth | -0.53 -8.16% | -0.60 | 0.07 | 11.18% |
| Q2 2022 Q2Q % growth | -0.43 -19.44% | -0.62 | 0.19 | 30.32% |
| Q1 2022 Q2Q % growth | -0.59 -1.72% | -0.56 | -0.03 | -6.13% |
| Q4 2021 Q2Q % growth | -0.45 47.67% | -0.61 | 0.16 | 26.47% |
| Q3 2021 Q2Q % growth | -0.49 41.67% | -0.64 | 0.15 | 23.75% |
| Q2 2021 Q2Q % growth | -0.36 29.41% | -0.67 | 0.31 | 46.25% |
| Q1 2021 Q2Q % growth | -0.58 46.30% | -0.72 | 0.14 | 19.91% |
| Q4 2020 Q2Q % growth | -0.86 14.00% | -0.92 | 0.06 | 6.66% |
| Q3 2020 Q2Q % growth | -0.84 6.67% | -0.85 | 0.01 | 1.08% |
| Q2 2020 Q2Q % growth | -0.51 43.33% | -0.73 | 0.22 | 30.56% |
| Q1 2020 Q2Q % growth | -1.08 -620.00% | -1.04 | -0.04 | -4.32% |
| Q4 2019 Q2Q % growth | -1.00 | -1.07 | 0.07 | 6.63% |
| Q3 2019 Q2Q % growth | -0.90 | -1.12 | 0.22 | 19.78% |
| Q2 2019 Q2Q % growth | -0.90 | -1.07 | 0.17 | 15.97% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -3.53% | 0% | 28.57% |
| Revenue | N/A | N/A | 0% | -21.45% |